논문KCI 등재
Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (8)
관련 논문AI추천
Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”Ahmed O. Kaseb, Ji Hoon Kim, Ju-Seog Lee, Sung Hwan Lee, Sunyoung S. Lee, Sun Young Yim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”Ahmed O. Kaseb, Ji Hoon Kim, Ju-Seog Lee, Peng Wei, Sung Hwan Lee, Sunyoung S. Lee, Sun Young Yim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”Hiroaki Kanzaki, Yujin Hoshida대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Personalized approaches to the treatment of hepatocellular carcinoma using immune checkpoint inhibitors: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”Naoshi Nishida대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”Hiroaki Kanzaki, Yujin Hoshida대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/ bevacizumab failure: A real-world study”Dong Yun Kim, Do Young Kim, Hong Jae Chon, Young Eun Chon대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호
이 간행물의 다른 논문 (84건)
Roles of X-box binding protein 1 in liver pathogenesisYun Seok Kim, Jihoon Tak, Sang Geon Kimpp. 1-31Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screeningTian Xia, Jiawen Wangpp. 1-2KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025Eun Joo Lee, Jung Hee Kim, Byoung Kuk Jang, Miyoung Choi, Su Jong Yu, Young-Sun Lee, Young-Joo Jin, Hye Won Lee, Soon Sun Kim, Pil Soo Sung, Young Kul Jung, Gi-Ae Kim, Young Chang, Won Sohn, Jeong-ju Yoopp. 1-31Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHua Lu, Xiao-Song Li, Xi-Ping Shen, Hang Lipp. 3-4Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adultsDonghee Kim, Aijaz Ahmed, Won Kimpp. 5-7